眼血流作为临床观察指标:价值、局限性与数据分析
本文综述了眼血流改变作为多种眼病发病和进展重要风险因素的证据,指出基于人群和纵向研究已提供血流动力学生物标志物作为独立风险因素的 compelling 证据,但血流与其他风险因素和合并症的相对贡献仍不确定。目前缺乏评估眼部所有相关血管床的金标准,多种眼成像技术衍生的血管生物标志物不可互换且难以整体解读,标准统计方法常产生不一致结果。文章提出结合数学建模与人工智能进行数据分析,以实现个体化风险评估和精准医学。
要点
- 眼血流改变是多种眼病发病和进展的重要风险因素,人群和纵向研究提供血流动力学生物标志物作为独立风险因素的证据。
- 目前无评估眼部所有相关血管床的金标准,多种眼成像技术衍生的血管生物标志物不可互换且难以整体解读。
- 结合机制驱动数学建模与人工智能有望克服标准统计方法的局限,实现个体化风险评估和精准医学。
核心结论
- 眼血流改变是多种眼病的重要风险因素,但血流与其他风险因素和合并症的相对贡献仍不确定。
- 缺乏评估眼部所有相关血管床的金标准,血管生物标志物不可互换且难以整体解读。
- 结合数学建模与人工智能有望推进眼科数据分析,实现个体化风险评估和精准医学。
研究设计与样本
- 本文为综述,回顾了眼血管解剖与生理、眼成像技术、青光眼及其他眼病临床发现和机制建模预测的现状与主要未解问题。
主要发现
- 基于人群和纵向研究提供了血流动力学生物标志物作为眼病独立风险因素的 compelling 证据,跨越多个地理区域。
- 标准统计方法常产生不一致结果,无法量化或解释患者整体眼病风险。
- 机制驱动数学建模可构建虚拟实验室研究致病机制、提升诊断能力和改善疾病管理。
- 人工智能提供利用广泛患者类型的大量数据来诊断和监测眼病的新方法。
临床怎么用
- 临床观察眼血流需认识到现有成像技术衍生的血管生物标志物不可互换且难以整体解读。
- 可探索结合数学建模与人工智能进行整合数据分析,以克服标准统计方法的局限并实现个体化精准医学。
局限性
- 血流与其他风险因素和合并症的相对贡献仍不确定。
- 目前无评估眼部所有相关血管床的金标准。
- 多种眼成像技术衍生的血管生物标志物不可互换且难以整体解读。
- 标准统计方法常产生不一致结果,无法量化或解释患者整体眼病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alterations in ocular blood flow have been identified as important risk factors for the onset and progression of numerous diseases of the eye. In particular, several population-based and longitudinal-based studies have provided compelling evidence of hemodynamic biomarkers as independent risk factors for ocular disease throughout several different geographic regions. Despite this evidence, the relative contribution of blood flow to ocular physiology and pathology in synergy with other risk factors and comorbidities (e.g., age, gender, race, diabetes and hypertension) remains uncertain. There is currently no gold standard for assessing all relevant vascular beds in the eye, and the heterogeneous vascular biomarkers derived from multiple ocular imaging technologies are non-interchangeable and difficult to interpret as a whole. As a result of these disease complexities and imaging limitations, standard statistical methods often yield inconsistent results across studies and are unable to quantify or explain a patient's overall risk for ocular disease. Combining mathematical modeling with artificial intelligence holds great promise for advancing data analysis in ophthalmology and enabling individualized risk assessment from diverse, multi-input clinical and demographic biomarkers. Mechanism-driven mathematical modeling makes virtual laboratories available to investigate pathogenic mechanisms, advance diagnostic ability and improve disease management. Artificial intelligence provides a novel method for utilizing a vast amount of data from a wide range of patient types to diagnose and monitor ocular disease. This article reviews the state of the art and major unanswered questions related to ocular vascular anatomy and physiology, ocular imaging techniques, clinical findings in glaucoma and other eye diseases, and mechanistic modeling predictions, while laying a path for integrating clinical observations with mathematical models and artificial intelligence. Viable alternatives for integrated data analysis are proposed that aim to overcome the limitations of standard statistical approaches and enable individually tailored precision medicine in ophthalmology.
引用
- Harris A, Guidoboni G, Siesky B, et al. Ocular blood flow as a clinical observation: Value, limitations and data analysis. Prog Retin Eye Res. 2020. PMID: 31987983. doi:10.1016/j.preteyeres.2020.100841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。